SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
-4.39%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$29.1M
AUM Growth
+$29.1M
(+8%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-35.87%
Top 10 Holdings %
Top 10 Hldgs %
46.3%
Holding
104
New
18
Increased
15
Reduced
30
Closed
22
Top Buys
| 1 |
BCLI
BRAINSTORM CELL THERAPUTC
BCLI
|
$2.61M |
| 2 |
BIOR
Biora Therapeutics, Inc. Common Stock
BIOR
|
$1.86M |
| 3 |
Sidus Space
SIDU
|
$1.16M |
| 4 |
Iterum Therapeutics
ITRM
|
$1.13M |
| 5 |
Sonnet BioTherapeutics
SONN
|
$1.02M |
Top Sells
| 1 |
Verb Technology
VERB
|
$9.7M |
| 2 |
BBLG
Bone Biologics
BBLG
|
$2.13M |
| 3 |
NiSun International Enterprise Development Group
NISN
|
$1.81M |
| 4 |
OceanPal Inc. Common Stock
OP
|
$1.38M |
| 5 |
Infobird
IFBD
|
$1.31M |
Sector Composition
| 1 | Healthcare | 61.39% |
| 2 | Industrials | 9.14% |
| 3 | Consumer Discretionary | 8.41% |
| 4 | Communication Services | 4.7% |
| 5 | Consumer Staples | 4.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCLI
1
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $2.61M | 2.14% | +1,267,871 | New | +$2.61M |
|
|
BIOR
2
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $1.86M | 1.52% | +482,609 | New | +$1.86M |
|
|
3
Sonnet BioTherapeutics
SONN
$22M
| $1.61M | 1.32% | 3,291,060 +2,075,526 | +171% | +$1.02M |
|
|
AKTX
4
Akari Therapeutics
AKTX
$24.8M
| $1.26M | 1.03% | 7,392,131 -549,736 | -7% | -$93.5K |
|
|
5
Sidus Space
SIDU
$32.1M
| $1.16M | 0.95% | +6,413,644 | New | +$1.16M |
|
|
6
Iterum Therapeutics
ITRM
$30.2M
| $1.13M | 0.92% | +75,000 | New | +$1.13M |
|
7
Recon Technology
RCON
$64.6M
| $1.09M | 0.89% | 3,154,278 -793,400 | -20% | -$273K |
|
|
TC
8
TuanChe
TC
$443M
| $996K | 0.81% | 1,991,476 -454,996 | -19% | -$227K |
|
|
9
NiSun International Enterprise Development Group
NISN
$18.4M
| $892K | 0.73% | 241,999 -491,721 | -67% | -$1.81M |
|
10
Dogness International Corp
DOGZ
$152M
| $853K | 0.7% | 1,169,116 -682,515 | -37% | -$498K |
|
11
GlucoTrack
GCTK
$3.8M
| $702K | 0.57% | +2,032,833 | New | +$702K |
|
|
NMTR
12
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $698K | 0.57% | 1,038,440 -65,205 | -6% | -$43.8K |
|
13
SHF Holdings
SHFS
$7M
| $669K | 0.55% | 1,262,779 +98,865 | +8% | +$52.4K |
|
|
ATXI
14
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $647K | 0.53% | 553,338 +273,440 | +98% | +$320K |
|
|
MRAI
15
DELISTED
Marpai, Inc. Class A Common Stock
MRAI
| $643K | 0.53% | +375,968 | New | +$643K |
|
16
Safety Shot
SHOT
$61.7M
| $597K | 0.49% | 1,421,797 -477,192 | -25% | -$200K |
|
17
Ensysce Biosciences
ENSC
$6.2M
| $580K | 0.47% | +322,298 | New | +$580K |
|
|
FRZA
18
DELISTED
Forza X1, Inc. Common Stock
FRZA
| $578K | 0.47% | +393,411 | New | +$578K |
|
19
Soligenix
SNGX
$10.1M
| $573K | 0.47% | +814,245 | New | +$573K |
|
|
PBLA
20
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
| $542K | 0.44% | 235,819 -190,544 | -45% | -$438K |
|
21
Pulmatrix
PULM
$18M
| $493K | 0.4% | 184,074 -35,955 | -16% | -$96.4K |
|
22
Tharimmune
THAR
$31.4M
| $483K | 0.4% | +1,325,219 | New | +$483K |
|
|
BETS
23
DELISTED
Bit Brother Limited Class A Ordinary Shares
BETS
| $479K | 0.39% | 911,464 +175,367 | +24% | +$92.1K |
|
|
HCDI
24
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
| $466K | 0.38% | +154,143 | New | +$466K |
|
25
Arcadia Biosciences
RKDA
$5.28M
| $459K | 0.38% | 118,213 +65,339 | +124% | +$254K |
|